Antiviral medication to reduce symptoms of COVID-19: A

Recruiting

18 years - 64 years

All

Phase 3

40 participants needed

1 Location

Brief description of study

If you tested positive for COVID-19 within the last 5 days, you may be eligible to participate in a research study to test the ability of a pill to reduce COVID-19 symptoms.

Detailed description of study

What is the medication that is being tested?

The study medication is an antiviral pill that is designed to reduce symptoms of COVID-19

Is there payment for taking part in this study?

Participants who complete all expected parts of the study will earn $500

Am I eligible to join this study?

To find out and to learn more, please fill out the screening form below

__________________________________________________________

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: COVID-19
Age: 18 years - 64 years
Gender: All

Updated on 04 Aug 2024. Study ID: 851173

Pre-Screener

Check if you are eligible Enter contact details Select a study center Select best time to contact

Are you between the age of 18 and 64?

Yes No

Preview complete

The prescreener preview is complete. You may now close the preview.